AquaBounty Technologies (AQB) vs. The Competition Head-To-Head Review

AquaBounty Technologies (NASDAQ:AQB) is one of 844 public companies in the “Biotechnology” industry, but how does it contrast to its competitors? We will compare AquaBounty Technologies to similar companies based on the strength of its earnings, valuation, profitability, risk, dividends, institutional ownership and analyst recommendations.

Institutional & Insider Ownership

8.9% of AquaBounty Technologies shares are held by institutional investors. Comparatively, 47.9% of shares of all “Biotechnology” companies are held by institutional investors. 1.0% of AquaBounty Technologies shares are held by insiders. Comparatively, 12.9% of shares of all “Biotechnology” companies are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Valuation & Earnings

This table compares AquaBounty Technologies and its competitors revenue, earnings per share (EPS) and valuation.

	Gross Revenue	Net Income	Price/Earnings Ratio
AquaBounty Technologies	$2.47 million	-$18.49 million	-1.19
AquaBounty Technologies Competitors	$701.44 million	$12.42 million	-15.18

AquaBounty Technologies’ competitors have higher revenue and earnings than AquaBounty Technologies. AquaBounty Technologies is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.

Volatility and Risk

AquaBounty Technologies has a beta of 1.45, suggesting that its stock price is 45% more volatile than the S&P 500. Comparatively, AquaBounty Technologies’ competitors have a beta of 1.10, suggesting that their average stock price is 10% more volatile than the S&P 500.

Analyst Recommendations

This is a summary of current recommendations and price targets for AquaBounty Technologies and its competitors, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
AquaBounty Technologies	1	0	0	0	1.00
AquaBounty Technologies Competitors	9838	15122	45436	1587	2.54

As a group, “Biotechnology” companies have a potential upside of 102.62%. Given AquaBounty Technologies’ competitors stronger consensus rating and higher possible upside, analysts clearly believe AquaBounty Technologies has less favorable growth aspects than its competitors.

Profitability

This table compares AquaBounty Technologies and its competitors’ net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
AquaBounty Technologies	N/A	-147.07%	-35.44%
AquaBounty Technologies Competitors	-12,346.73%	-197.60%	-30.56%

Summary

AquaBounty Technologies competitors beat AquaBounty Technologies on 9 of the 12 factors compared.

AquaBounty Technologies Company Profile

AquaBounty Technologies, Inc., a biotechnology company, operates in the aquaculture industry in the United States and Canada. The company engages in genetic, genomic, and fish health and nutrition research activities. It also operates salmon farms using proprietary technology. In addition, the company offers AquAdvantage Salmon, a genetically engineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon, salmon eggs, fry, and byproducts. The company was formerly known as Aqua Bounty Farms, Inc. and changed its name to AquaBounty Technologies, Inc. in June 2004. AquaBounty Technologies, Inc. was incorporated in 1991 and is headquartered in Harvard, Massachusetts.